glp 1 addiction Not just obesity: GLP-1 receptor agonists advance on Hype Or Hope? Latest Research
Description
The poll fielded prior to President Trumps announcement last week related to the cost and coverage of GLP-1 drugs finds that about half of GLP-1 users (56%), including a similar share among those with insurance (55%), say that it was difficult to afford these drugs
Usually drugs that go into shortage are cheap generics, not expensive brand-name ones that are still under patent, Tenille Davis, PharmD, chief advocacy officer at the Alliance for Pharmacy Compounding, tells SELF
Boosting GLP-1 by Natural Products
Population-based cohort study
